The National Academies Press

Currently Skimming:

Index
Pages 325-339

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 325... ... , 155 - 156 AlAnon, 179, 181 - 182, 194 Alaproclate, 173 AlaTeen, 181 - 182 Alcohol. See also Alcohol dependence; Alcohol-related problems; Alcohol use administration in therapies, 176, 274 alternatives to, 117, 254 carbimide reactions, 172 cardiovascular effects, 278 - 279 disulfiram reactions, 171 effects on sleep, 273 - 275 emotional effects, 60 ingestion, testing for, 33 metabolism of, 33, 34, 40, 155 neuromuscular effects, 35 physiological and behavioral effects, 31 - 32 in public health model, 2, 24 - 25, 27 withdrawal, 169, 253 - 254, 268 - 275 Alcohol, Drug Abuse and Mental Health Administration (ADAMHA) Read the entire page →
From page 326... ... , vii, 20, 24 Alcohol-related cues, 258 Alcohol-related disorders, 235 Alcohol-related problems in assessment, 151 conceptualization, 10, 149, 223 continuum model of, vi, 1 - 2, 10, 23 diversity of, 144 epidemiology, 2 - 3, 31, 44 implications of public health research, 121 - 123 in primary care, 224 progression of, 222 public health model of, 2, 24 - 27 secondary prevention of, 215 Alcohol use attitudes about, 247 biological markers of, 153, 155 - 157 and blood pressure, 278 - 279 community prevention research, 10~110 concomitant drug use, 235, 238, 258 consumption rates advertising and, 85 availability and, 6, 75, 76 - 77, 128 context and setting effects, 6, 91, 92 minimum purchase age and, 6, 78 - 80 prices and, 6, 76, 77 - 78, 81, 129, 13~131 zoning and conditionaluse permits and, 80 costs of, 23 cultural drinking behavior, 60, 92, 129 health consequences, 15, 267 historical patterns, 128 identification of at-risk individuals, 47 mortality, vi, 1, 23 periodic problem drinking, 53 severity of, 13, 234 smoking and, 247 - 248 in smoking prevention studies, 119 social learning of, 58 - 59 testing for, 11, 155-7 Alcohol Use Inventory, 152 Alpha-2 adrenergic agonists, 268 Alzheimer's disease, 278 American Hospital Association Annual Survey, 161 American Medical Association, 176 -326 Read the entire page →
From page 327... ... , 155 - 156 Assertiveness training, 183 Assessment technology, 15~158 Attention-span deficit, 54 Attribution for change, 249 Australia, 89, 115 Automobile accidents alcohol and, 3, 23, 31, 33, 35, 78 alcohol prices and, 77 blood alcohol level in, 8% drunk driving laws and, 6, 89, 90 epidemiology, 34 minimum purchase age and, 79 risk for, 88 seat belt use and, 116 Autopsy, 33 Autoregression, 129 Aversion therapies, 11 - 12, 175? 191, 253 Baltimore, 120 Bars, 26, 92 Bartenders, 131 Beer consumption advertising and, 85 decline in, 145 pitcher sales and, 91 price and, 77 purchase age and, 78, 7~80 Behavioral development, 48 Behavioral risk factors, 49, 215 Behavioral self-control training, 18~181, 215 effectiveness of, 11 - 12, lg6 and moderation outcome goals, 219 Behavioral therapy, 253 Behavior change attribution for, 249 education and, 120 legislation and, 116 motivation for, 12, 63 64, 65, 193 - 195, 235, 251 - 252 readiness to, 5, 63 64, 65, 235, 248 smoking cessation, 253, 261 stages of, 248 Behavior change theory, 123 Benzodiazepines, 259, 268, 270, 271, 272 Beta blockers, 268, 279 Biochemical imbalances, 57 Biochemical tests, 221 Biofeedback-assisted relaxation training, 183 Biological markers, 11, 66, 153, 155 - 157, 221 - 222 Biological vulnerabilities, 57, 149 Biomedical research, 8, 132 Bipolar affective disorder, 174 Birth defects, maternal drinking and, 40 Bisexuals, 39 Blacks cancer in, 117 hypertension in, 278-279 smoking rate, 255 Blood alcohol concentrations (BAC) Read the entire page →
From page 328... ... , 269 Clinical trials difficulties of, 291, 314 early intervention, 221 multicenter, 160, 162 Clinical Trials Cooperative Groups, 316 Clonidine, 252, 268 Cocaine craving, 258, 259 dependence, 259, 260, 272 dependence treatment, 256, 319, 320 Cocaine-alcohol dependency, 235, 238 Codependence, 145, 146 Cognitive-behavioral mediators, 65 Cognitive-behavioral processes, 57 Cognitive-behavioral therapy, 177, 184 Cognitive impairment, 15, 178, 267, 275 - 277 Cognitive restructuring, 5, 62~3, 177, 183, 277 - 278 Cognitive variables, 248-249 Cohort effects, 48, 55 - 56 College prevention programs, 129 Communication-behavior change model, 112 Communication-persuasion model, 112 Community change, 114 initiatives, 311 mental health centers, 143 reinforcement, 183, 197 as risk factor, 49, 50 Community Mental Health Centers Act, 141 Community organization model, 112, 113 Community-wide prevention, 7 - 8, 64, 130 alcohol, 10~110, 128 cardiovascular disease, 7, 27, 111 - 115 cost of data collection, 133 implications from other public health fields, 121 - 123 ~JIAAA and, 309 CompCare, 185 Compliance, 12, 193 - 194 with disulfiram therapy, 159, 171 Composite International Diagnostic Intelview, Substance Abuse Module (CID I-SAM) , 1 50 Comprehensive Drinker Profile, lS0 Computerized assessments, 154, 157 Computer modeling, 129, 132, 133 - 134 Conditioned response, 58, 6(}61, 257 - 258 counterconditioning, 175 Condoms, 39 Confounding variables, 161 -328 Read the entire page →
From page 329... ... behavioral self-control training and, 18~181 deaths from accidents, 23, 34, 78 drinking context and, 26, 93 education programs, 10, 84, 142 legal environment, 6, 87~0, 129 public interest groups on, 145 treatment programs, 194 and vehicular injuries, 34, 35 Drowning, 3, 31, 36 Drug use alcohol use and, 88 -329 Read the entire page →
From page 330... ... , 144, 234, 235 Family therapy, 12, 181 - 182, 197, 24(}241 Federal employees alcohol program, 142 Feedback designs, 233, 242 Females alcohol-related problems in, 144 fire death risks, 37 inhibition of risk in, 55 pregnant, interventions with, 13, 142, 217 - 218 in prospective research, 52 in public information campaigns, 84 remission of problem drinking in, 53 and smoking cessation, 255 television and, X? treatment matching, 237, 238 Fermentation, 34 Fetal alcohol effects, 3, 13, 41, 217 - 218 Fetal alcohol syndrome (FAS) Read the entire page →
From page 331... ... See also Females; Males Genetic determinants in aversion therapy, 176 of maternal alcohol metabolism, 40, 41 of risk for alcohol problems, 5, 47, 49, 66, 222 Great Britain, 89 Group psychotherapy, 177, 194, 239, 257 Hallucinosis, 272 Ha lo perido l , 272 Happy hours, 77, 129, 131 Hazelden treatment model, 185 Head Start, 255 Health care cost offset of treatment, 15 - 16, 292 - 296, 299 costs, 15 Health Care Financing Administration, 316 Health care professionals, 13, 224 Health consciousness, 59, 145 Health insurance and adolescent care, 300 cost offsets and, 292 costs, 296 - 299 industry, 236, 315, 319 policy analysis, 290 reimbursement policy, 9, 142, 188, 224, 236, 240, 297 and smoking Cessation, 255 Health maintenance organizations (HMO) , 143, 215, 294, 298, 299 Heart, 282 Heavy drinkers, vi, 23 and alcohol-related problems, 144 biological markers and, 221 brief interventions and, 216 cardiovascular risks, 278 differentiation of, 131 and expectancies, 60 health risks, 282 interventions for, 145 liver effects, 280 - 281 self-monitoring training, 62 stroke risk, 279 treatment recruitment, 223 Hematopoietic system, 282 Hemoglobin acetaldahyde adduct (Al factor, 156 Hepatic cirrhosis, 156, 28~281 mortality, 15, 267 as surrogate measure of drinking, 77 Hepatitis, 155, 156, 280-281 Heroin addicts, 181 High-density lipoprotein cholesterol (HDLC) Read the entire page →
From page 332... ... See also Hepatic cirrhosis; Hepatitis disease, 23 dysfuntion, 37 effects of alcohol on, 15, 280 281 enzymes, 155 - 156, 216 transplantation, 281 Lofexidine, 268 Longitudinal research, 133, 146 data bases, 56 methodological problems, 295 Lorazepam, 270 Los Angeles, 119 Maine, 89 90, 129 Males alcoholic fathers and, 54 comorbidities in, 235 remission of problem drinking in, 53 risk factors, 4, 37, 52 Managed care, 16, 296, 298 Mandated treatment, 12, 145, 194 - 195 Marijuana, 34 community prevention research, 109 in smoking prevention studies, 119 Marital conflict, 4, 52 Marital therapy, 181 - 182, 197 Massachusetts drunk driving laws, 89 minimum drinking age, 78 - 79 Media alcohol advertising, 6, 85 - 86 in community prevention studies, 7, 111, 117, 128 fictional depictions of alcohol use, 6, 86 - 87 public information campaigns, 6, 82 - 85, 88, 89 in smoking prevention, 119 social learning and, 58, 60 treatment recruitment, 143, 162, 223 Medication, 196 abuse and dependence, 174 in smoking cessation, 252 Meditation, 183 Memos, 154, 275 - 276 training, 277 -332 Read the entire page →
From page 333... ... , 90 Moderate drinkers, 23 biological markers in, 156 differentiation of, 131 and environmental factors, 24 in treatment outcome, 21~220 Moderation, as treatment goal, 13, 61, 218 - 220, 223 Moral deficiencies, 57 Mortality alcohol availability and, 76, 77 alcohol use, vi, 1, 23 automobile accidents, 23, 34, 78 cardiovascular disease, 112, 255 cirrhosis and hepatitis, 15, 77, 267, 280 drowning, 36 early intervention and, 224 falls, 35 fire and burns, 37 injuries, 3, 31 Mothers Against Drunk Driving, 87, 110 Motivation for change, 12, 63 64, 65, 193 - 195, 235, 251 - 252 Movie theaters, 84 Multistage sampling, 56 Multivariate analysis, 55, 129, 131, 161, 232 Muscle, 282 Music Television, 84 Mutual help groups, 11 - 12, 119, 178 - 180 Naloxone, 267 Naltrexone, 259 Narcotics Anonymous, 186, 300 National Alcoholism and Drug Abuse Program Inventory (NDAPI) , 161 National Alcoholism Program Information System (NAPIS) Read the entire page →
From page 334... ... See Driving-while-intoxica ted Opiate abuse, 258, 272, 319 antagonists, 173 withdrawal, 259 Organ damage, 154, 155, 267 Osteoporosis, 35 Outcome. See Treatment: effectiveness of Outpatient treatment, 183, 216 costs, 291, 293 patient-treatment matching, 239, 240, 241 social supports and, 13, 234 Oxazepam, 269 - 270 Pancreas, 282 Paranoia, 272 Partial correlation, 161 Path-analytic procedures, 132 Patient-treatment matching, 13 - 14, 14~150, 237 - 241 methodology, 231 - 233 patient measurement, 233 - 235, 241 readiness to change and, 248 recommendations, 241 - 242, 315 treatment measurement, 235 - 236 Pavlovian learning theory, 191 Pawtucket Heart Health Study, 115, 129 Peer groups coping skills training and, 61, 119 as risk factor, 49, 50, 55 social learning and, 58, 60 Pennsylvania, 115 Per se laws, 87, 88 Personality tests, 234 Personality variables, 49 Pharmacotherapies, 11 - 12, 17~175, 261 alcohol withdrawal, 268 - 269 drug dependence, 25~260 Phenobarbital, 271 Phenothiazine, 312 Physical deformities, maternal drinking and, 40 Physician counseling, 254 Physiological indicators of susceptibility, 66 Placebo therapy, 217 Planned Approach to Community Health, 310 Platelet monoamine oxidase, 156 Point-of-purchase components, 115 Police enforcement, 88 - 89, 131 Policy development, vii, 9, 15 - 16, 20, 133 - 134 -334 Read the entire page →
From page 335... ... , 150 Psychiatric disorders alcoholism comorbidity, 144, 153, 174, 177, 178, 241, 319 diagnosis, 13, 150, 234 drug dependence comorbidity, 261 and medical care utilization, 297 and treatment outcome, 152 Psychological interventions, 173 Psychological learning theory, 152 Psychosis, 170, 319 Psychotherapy, 11 - 12,177 - 178,240,261 in drug treatment, 256 - 257 Psychotropic medication, 170, 174, 178, 257 Public health model of alcohol-related problems, 2, 24 - 27 Public Health Service, 18, 316 Public Health Service Act, 315 Public information campaigns, 6, 82 - 85 Public service announcements, 84, 113 Punishment, 60 Quanine nucleotide, 156 Quasi-experimental designs, 129, 131, 198 data for, 157 methodology, 8, 159, 16~161 patient-treatment matching, 232 treatment evaluation, 187 Radio, 84 Rand Corporation, 142, 298, 315 Readiness to change, 5, 63~4, 65, 235, 248 Recall cues, 155 Reciprocal determinism, 57 Red blood cells, mean corpuscular volume (MCV) , 156, 221 Reinforcement, 60 61 Relapse prevention, 11 - 12,169,170,235 alcohol administration in, 176 broad-spectrum treatment in, 182 calcium carbimide in, 172 compliance, 194 outcome research, 184 - 185 patient-treatment matching, 24~241, 242 research on, 152, 18~190 smoking, 250 Research See also Methodology; Prevention research; Research opportunities; Treatment formative, 83 - 84, 113 - 114, 130, 133 -335 Read the entire page →
From page 336... ... 121 Secondary prevention, 2, 26, 53, 215, 221 coping skills training, 61ff2, 65 Seizures, treatment of, 27~271 Selected interventions, 2, 26, 64 life-course development and, 53 - 54 Self-efficacy, 5, 58, 59, 65, 184, 191, 248, 249 Self-esteem, 57, 177 Self-help, 239 manuals, 13, 112, 215 - 216, 223, 235, 253 smoking cessation, 261 Self-monitoring, 5, 62, 253 Self-regulation, 57, 58, 60 Self-selection, treatment, 233, 237 - 238 Serotonin uptake inhibitors, 173 -336 Read the entire page →
From page 337... ... See Midwestern Prevention Project State laws alcoholic beverage control (ABC) commissions, 75, 76 drinking age, 87 drunk driving, 87~0 seat belt use, 116 Stomach, 282 Stress management training, 183, 197 Stroke, 279 Structural modeling, 132 Structured diagnostic interviews, 152 Student assistance programs, 21S Students Against Drunk Driving, 87, 110 Suicide, 3, 36, 38 Surgeon General's Report on Smoking and Health (1964) Read the entire page →
From page 338... ... See Risk factors Warning labels, 41 Washington, D.C., 76, 117 Washington, University of, 40 Wernicke-Korsakoff syndrome, 275 Wine consumption, advertising and, 85 Women. See Females Women for Sobriety, 179 Work setting, as risk factor, 49, 50, 93 Work site prevention trials, 128, 130 -338 Read the entire page →
From page 339... ... Mark sHe-b=~ in=nl~, 8, 116, 117, 120 ma_ ~, 1 alcohol awry pm~m, 319 Sol Use Dbo~e~ Identi0=lion ~1 (AIDS, 2~ ~1~1 Pawn ~5 ~meUdine, 173, ~7, 278 atoning and ~ndidonaL~e permits 76, -339 Read the entire page →

From page 325...

... , 155 - 156 AlAnon, 179, 181 - 182, 194 Alaproclate, 173 AlaTeen, 181 - 182 Alcohol. See also Alcohol dependence; Alcohol-related problems; Alcohol use administration in therapies, 176, 274 alternatives to, 117, 254 carbimide reactions, 172 cardiovascular effects, 278 - 279 disulfiram reactions, 171 effects on sleep, 273 - 275 emotional effects, 60 ingestion, testing for, 33 metabolism of, 33, 34, 40, 155 neuromuscular effects, 35 physiological and behavioral effects, 31 - 32 in public health model, 2, 24 - 25, 27 withdrawal, 169, 253 - 254, 268 - 275 Alcohol, Drug Abuse and Mental Health Administration (ADAMHA)

Index Pages 325-339

Index
Pages 325-339